Mutations

MAPT V75A

Overview

Pathogenicity: Frontotemporal Dementia : Unclear Pathogenicity
Clinical Phenotype: Frontotemporal Dementia
Genomic Mutation Name (MET1): g.12051T>C
Genomic Mutation Name (NT1): g.84967T>C
dbSNP ID:
Coding/Non-Coding: Coding
Genomic Region: Exon 3
Mutation Type: Point, Missense
Codon Change: GTG to GCG

Findings

This mutation was reported in a 41-year-old man who developed memory impairment and disturbed behavior at age 35. He was hospitalized at age 40, developed seizures, and became mute. A sister developed a similar dementia syndrome characterized by insidious onset, loss of social awareness and absence of insight, starting around age 31 with personality changes and behavioral disturbances. A paternal aunt and the paternal grandmother were affected by Alzheimer’s disease and Parkinson’s disease, respectively. Both affected siblings were found to carry the previously described PSEN2 mutation R62H. In addition, the brother carried a novel V75A mutation in MAPT. Both the MAPT and PSEN2 mutations were absent in two healthy brothers and 200 control samples, but the pathogenic roles of these variants are unclear (Gallo et al., 2010).

Neuropathology

Frontotemporal atrophy and fronto-mesial and parietal left hypoperfusion by CT, MRI and SPECT (Gallo et al., 2010).

Biological Effect

Unknown.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

Mutations Citations

  1. PSEN2 R62H

Paper Citations

  1. . Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia. Neurol Sci. 2010 Feb;31(1):65-70. Epub 2009 Sep 19 PubMed.

Further Reading

Learn More

Alzheimer Disease & Frontotemporal Dementia Mutation Database

Primary Papers

  1. . Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia. Neurol Sci. 2010 Feb;31(1):65-70. Epub 2009 Sep 19 PubMed.